No shortage on file

MAR-AMITRIPTYLINE

MARCAN PHARMACEUTICALS INC

Quick answers

Is there a shortage of MAR-AMITRIPTYLINE in Canada?

No. There is no current shortage of MAR-AMITRIPTYLINE 10MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AMITRIPTYLINE 10 TAB

DUCHESNAY INC

10MG · DIN 00448796

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ELAVIL TABLET 10MG

1560678 ONTARIO INC.

10MG · DIN 00016322

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

AMITRIPTYLINE HCL TAB 50MG

D.C. LABS LIMITED

50MG · DIN 00377899

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ELAVIL TABLET 75MG

1560678 ONTARIO INC.

75MG · DIN 00354295

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NOVO-TRIPTYN TAB 25MG

NOVOPHARM LIMITED

25MG · DIN 00037419

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-AMITRIPTYLINE

PRO DOC LIMITEE

50MG · DIN 00456349

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Apo-Amitriptyline

Apo-Amitriptyline: Affected lots may exceed the interim acceptable intake limit for NNORT

Type I2024-10-17

Highest health risk

Possible match — not confirmed

AMITRIPTYLINE 10 & 50mg

AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity

Type I2023-08-16

Highest health risk

Possible match — not confirmed

APO-AMITRIPTYLINE 10mg

APO-AMITRIPTYLINE 10mg: NDMA Impurity

Type I2023-02-07

Highest health risk

Possible match — not confirmed

APO-AMITRIPTYLINE 10mg

APO-AMITRIPTYLINE 10mg: NDMA impurity

Type I2022-01-26

Highest health risk

Possible match — not confirmed

DIN

02429861

Strength

10MG

Dosage Form

Tablet

Route

Oral

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

See all AMITRIPTYLINE HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from MARCAN PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION USP

500MG · DIN 02537893

AMIKACIN SULFATE INJECTION USP

500MG · DIN 02481073

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02554364

BICNU

100MG · DIN 02555093

BICNU

100MG · DIN 00297763

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02493306